Skip to main content

Day: September 20, 2021

Fulcrum Therapeutics™ Announces Multiple Presentations During the Virtual Congress of the World Muscle Society

– Presentations highlight progress in the development of losmapimod for FSHD – CAMBRIDGE, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced it will present multiple posters and presentations on losmapimod for facioscapulohumeral muscular dystrophy (FSHD) during the Virtual Congress of the World Muscle Society. These results highlight progress made in the development of losmapimod for the treatment of FSHD as well as imaging modalities for the management of FSHD. “FSHD is a serious, relentless and debilitating disease for which there are currently no approved therapies,” said Chris Morabito, MD, Fulcrum’s chief medical officer. “The results from the Phase...

Continue reading

EnviroGold Global to recover valuable commodities while rehabilitating the Buchans River Delta in Newfoundland, Canada

TORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) — EnviroGold Global Limited (“EnviroGold Global” or the “Company”) (CSE: NVRO), a Clean Technology Company accelerating the world’s transition to a circular-resource economy through the production of metals without mining, is pleased to announce the execution of binding commercial agreements adding the Buchans River Delta Reclamation Project (the “Buchans Project”) to its portfolio of Environmental Remediation and Asset Reclamation Projects. The Buchans Project includes approximately 1,225 hectares (3,025 acres) of mining claims located in the Canadian Province of Newfoundland and Labrador. Consistent with the Company’s strategy of reclaiming valuable and strategic commodities while remediating legacy and other environmental hazards, EnviroGold Global anticipates commissioning recovery and...

Continue reading

Atlas Technical Consultants to Attend the D.A. Davidson 20th Annual Diversified Industrials & Services Virtual Conference

AUSTIN, Texas, Sept. 20, 2021 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading Infrastructure and Environmental solutions provider, announced today that senior management of the Company will participate in the D.A. Davidson 20th Annual Diversified Industrials & Services Virtual Conference on Wednesday, September 22, 2021. About Atlas Technical Consultants Headquartered in Austin, Texas, Atlas is a leading provider of Environmental (ENV), Testing, Inspection & Certification (TIC), Engineering & Design (E&D), and Program, Construction, and Quality Management (PCQM) services. Under the name Atlas Technical Consultants, we offer solutions to public and private sector clients in the transportation, commercial, water, government, education, and industrial markets....

Continue reading

Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference

NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will present at the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 10:40 AM (ET). The conference is being held September 27-30, 2021. A live audio webcast will be available at https://wsw.com/webcast/cantor12/avxl.ob/2514820 or on the Company’s website at www.anavex.com. A webcast replay will be accessible for 30...

Continue reading

Global Powersports leader selects TrackX as its company-wide vehicle inventory management solution

TrackX becomes central source for vehicle inventory information TrackX Control Tower leveraged for reporting and analytics Integration with multiple operational systems Vehicles are tracked via GPS tags Driving logistics savings and delivery efficienciesDENVER, Sept. 20, 2021 (GLOBE NEWSWIRE) — TrackX Holdings Inc. (TSXV:TKX), (OTC:TKXHF), (FSE:3TH) (“TrackX” or the “Company), a leading provider of real-time end-to-end asset tracing, tracking and collaboration solutions announced today that global powersports leader, Polaris Inc., has selected the Company’s technology platform as its corporate vehicle inventory system of record. This announcement represents a significant expansion of the two companies’ long-standing partnership and demonstrates the return on investment that TrackX, a fully integrated hardware and cloud-based...

Continue reading

Immunocore presents data at the European Society for Medical Oncology (ESMO) Congress 2021 demonstrating a reduction in circulating tumor DNA (ctDNA) while on tebentafusp is associated with overall survival in the Phase 2 clinical trial

PRESS RELEASE Immunocore presents data at the European Society for Medical Oncology (ESMO) Congress 2021 demonstrating a reduction in circulating tumor DNA (ctDNA) while on tebentafusp is associated with overall survival in the Phase 2 clinical trial Linear correlation between the magnitude of ctDNA reduction on tebentafusp and improved overall survival 70% of evaluable patients had any ctDNA reduction and 14% had ctDNA clearance (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US (20 September 2021) Immunocore Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, presented new data from the Company’s lead program,...

Continue reading

Eden Empire Announces Joint Venture for Flagship Location

EDEN Cannabis Announces Flagship LocationVANCOUVER, British Columbia, Sept. 20, 2021 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “EDENTM” or “Eden Empire”) is thrilled to announce that it has entered into a share purchase agreement with a private arm’s length third party (the “Buyer”) to sell a 50% interest in its proposed Davie Street location for proceeds of $1,050,000CAD in cash. Following the closing date of the transaction, EDENTM will continue to operate the Davie Street location through a joint venture vehicle with the Buyer and it is expected that associated costs will be shared. Key Location Takeaways:Sits on the 1600 Block of Davie Street of Vancouver’s West End which is well-anchored with a new supermarket, drugstore, liquor store and soon-to-be cannabis...

Continue reading

Bunker Hill Announces Updated PEA: 42% Increase in NPV to $143M, 29% Decrease in AISC, 41% Increase in FCF Over Extended 11 Year Mine Life

Bunker Hill to Host a Webinar on Tuesday, September 21 @ 11:00am ET / 8:00am PT HIGHLIGHTS:Materially improved financial returns: 143M NPV (+42% increase), 35% IRR, 2.6 year payback, $25M annual average FCF (+28% increase) at $1.15/lb Zn, $0.90/lb Pb, $20/oz Ag (metal prices unchanged from April 2021 PEA) Increased use of Long-Hole Open Stoping mining drives a 29% reduction in AISC to $0.47 per pound of payable zinc Nearly 1 billion zinc equivalent pounds (including over 8 million ounces of silver) produced over an extended 11 year mine life.  The mine’s significant high-grade silver potential outside the current resource is not included CEO Sam Ash and CFO David Wiens to host live interactive 6ix virtual investor event on Tuesday, September 21st at 11:00AM ET / 8:00AM PT.  Investors are invited to register for this event at: [LINK] TORONTO,...

Continue reading

Avalo to Present at the 2021 Cantor Virtual Global Healthcare Conference

WAYNE, Pa. and ROCKVILLE, Md., Sept. 20, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases announced today that members of its senior management team will present in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference being held from September 27th through September 30th, 2021. 2021 Cantor Virtual Global Healthcare ConferenceDate: Wednesday, September 29th, 2021Time: 2:00 PM ET A live webcast of the fireside chat can be accessed under the “News/Events” page in the Investors section of the Company’s website at www.avalotherapeutics.com. About Avalo Therapeutics Avalo...

Continue reading

Yooma Wellness to Acquire Sparkling Water Brand Big Swig, Inc.

The acquisition of Big Swig’s sparkling water beverage business will add to the scope of Yooma’s brands and presence in the United States and create the opportunity for innovative new product offerings. TORONTO, Sept. 20, 2021 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma“) (CSE: YOOM, AQSE: YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has entered into definitive agreements to complete the acquisition of Big Swig, Inc. (“Big Swig”), a U.S. based seller of sparkling water beverages. The acquisition will increase Yooma’s presence in retailers located throughout the southern United States and add the Big Swig and Hard Swig brands to Yooma’s expanding portfolio, with opportunities for the creation of exciting new...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.